W. L. Gore & Associates · 23 hours ago
Tax Analyst
W.L. Gore & Associates is a $6 billion-dollar global manufacturing enterprise, and they are seeking an Income Tax Analyst to join their team. In this role, you will oversee state tax returns, support federal tax return processes, and implement process improvements using technology.
Health CareManufacturingMedical Device
Responsibilities
Maintain tax information, records, and relevant work papers for compliance. Prepare state tax returns, estimates, extensions, and other required reports accurately and on time
Perform quarterly and annual state tax provision tasks
Analyze and interpret tax laws and regulations and prepare technical documents on their impact on Gore’s tax operations
Prepare correspondence and interact with external tax agencies, consultants, and auditors
Support the federal tax return
Participate in special projects and perform other duties as assigned
Qualification
Required
Bachelor's degree in Accounting, Finance, or a related field
Minimum of 3 years of corporate income tax experience, with emphasis on state income tax (returns, extensions, and estimates) in a multi-state environment
Experience drafting and responding to tax agency correspondence/notices and partnering effectively with external advisors and auditors
Ability to research and interpret tax law, document conclusions, and prepare clear, audit-ready workpapers
Strong organizational, communication, and time-management skills with the ability to manage multiple deadlines in a recurring close/compliance calendar
Preferred
Experience with MS365, CoPilot, SAP, Alteryx, CSC Corptax, and Thomson Reuters Checkpoint
MST, CPA or other financial designations
Benefits
Comprehensive and competitive total rewards program
Benefits that offer choice and flexibility
Promote overall well-being
Distinctive Associate Stock Ownership Plan
Potential opportunities for 'profit-sharing'
Company
W. L. Gore & Associates
W. L. Gore & Associates is a global materials science company dedicated to transforming industries and improving lives.
Funding
Current Stage
Late StageRecent News
BioWorld Financial Watch
2026-01-11
Venture Capital
2026-01-06
Company data provided by crunchbase